ANHUI FENGYUAN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.33 CNY | +1.83% |
|
+11.96% | -11.10% |
| Sales 2022 | 4B 554M 756M | Sales 2023 | 4.28B 591M 808M | Capitalization | 3.11B 430M 588M |
|---|---|---|---|---|---|
| Net income 2022 | 154M 21.3M 29.09M | Net income 2023 | 159M 21.99M 30.03M | EV / Sales 2022 | 1.2 x |
| Net Debt 2022 | 304M 41.97M 57.33M | Net Debt 2023 | 368M 50.87M 69.48M | EV / Sales 2023 | 0.81 x |
| P/E ratio 2022 |
27.8
x | P/E ratio 2023 |
19.5
x | Employees | 4,654 |
| Yield 2022 |
0.74% | Yield 2023 |
-
| Free-Float | 64.81% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.83% | ||
| 1 week | +11.96% | ||
| Current month | +6.11% | ||
| 1 month | +6.11% | ||
| 3 months | +0.85% | ||
| 6 months | -15.77% | ||
| Current year | -11.10% |
1 week
7.52
8.58
1 month
7.038.58
Current year
5.969.60
1 year
5.9611.16
3 years
5.9616.98
5 years
5.5416.98
10 years
4.7619.99
| Managers | Title | Age | Since |
|---|---|---|---|
Tian Le Ru
CEO | Chief Executive Officer | 39 | 07-08-31 |
Jun Li
DFI | Director of Finance/CFO | 47 | 08-10-31 |
Yue E Hu
CHM | Chairman | 62 | 07-10-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Man He
CHM | Chairman | 52 | 08-03-17 |
Jun Zhang
BRD | Director/Board Member | 54 | 98-10-27 |
Wei Dong Zhu
BRD | Director/Board Member | 62 | 19-06-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 8.33 | +1.83% | 12,533,890 |
| 24-04-26 | 8.18 | +4.20% | 26,029,540 |
| 24-04-25 | 7.85 | +1.95% | 7,201,122 |
| 24-04-24 | 7.7 | +2.12% | 4,876,605 |
| 24-04-23 | 7.54 | +1.34% | 4,851,400 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotes
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, manufacture and distribution of biological medicines, chemical synthetic medicines and Chinese medicines. The Company's products mainly include antipyretic and analgesic, women and children, the nervous system, cardiovascular, urinary system, nutrition, antibiotics and active ingredient and other products. The Company is also engaged in the retailing and wholesale of drugs. The Company conducts its businesses mainly in domestic markets, with Anhui province as its main market.
Sector
Pharmaceuticals
Calendar
2024-05-22
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -11.10% | 375M | |
| +26.47% | 661B | |
| +26.74% | 566B | |
| -6.33% | 352B | |
| +19.35% | 332B | |
| +4.23% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.04% | 145B |
- Stock Market
- Equities
- 000153 Stock
